Completed NA INTERVENTIONAL 1-arm NCT03542162

Healaflow Patch for the Treatment of Rhegmatogenous Retinal Detachment

Patching Retinal Breaks With Healaflow in 27G Vitrectomy for the Treatment of Rhegmatogenous Retinal Detachment

Sponsor: Tianjin Medical University Eye Hospital

Conditions Rhegmatogenous Retinal Detachment

Interventions Healaflow

Updated 5 times since 2018 Last updated: Apr 29, 2019 Started: Jan 1, 2017 Primary completion: Jul 1, 2018 Completion: Dec 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03542162, this NA trial focuses on Rhegmatogenous Retinal Detachment and remains completed. Sponsored by Tianjin Medical University Eye Hospital, it has been updated 5 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
May 2019 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jun 2018 — May 2019 [monthly]

Active Not Recruiting NA

First recorded

Jan 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tianjin Medical University Eye Hospital

Data source: Tianjin Medical University Eye Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.